The diverse potential effector and immunoregulatory roles of mast cells in allergic disease

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 5, 2000, Pages 847-859

  Williams, Cara M M ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic inflammation; Allergy; Asthma; Atopy; Basophils; Chemokines; Eosinophils; Growth factors; IgE; Mast cells; Stem cell factor; T(H)2 cells

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY;

ALLERGIC DISEASE; ANIMAL CELL; CELL FUNCTION; CELL MATURATION; CYTOKINE PRODUCTION; HOST RESISTANCE; IMMUNOREGULATION; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW;

EID: 0034069624     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106485     Document Type: Article

References (166)

1. 1. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, Mem cell factor. Adv Immunol 1994;55:1-96.
2. 2. Galli SJ. Biology of disease: new insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotype heterogeneity. Lab Invest 1990;62:5-33.
3. 3. Kitamura Y. Heterogeneity of mast cells and phenotypic changes between subpopulations. Annu Rev Immunol 1989;127:191-8.
4. 4. Stevens RL, Austen KF. Recent advances in the cellular and molecular biology of mast cells. Immunol Today 1989;10:381-6.
5. 5. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77: 1033-79.
6. 6. Bienenstock J, Befus AD, Denburg JA. Mast cell heterogeneity: basic questions and clinical implications. In: Befus AD, Bienenstock J, Denburg JA, editors. Mast cell differentiation and heterogeneity. New York: Raven Press; 1986. p 391-402.
7. 7. Costa JJ, Galli SJ. Mast tells and basophils. In: Rich RR, editor. Clinical immunology: principles and practice. 1st ed. St Louis: Mosby; 1996. p 408-30.
8. 8. Schwartz LB, Huff TF. Biology of mast cells and basophils. In : Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr. Yunginger JW, Busse WW, editors. Allergy principles and practice. 4th ed. Vol 1. St Louis: Mosby; 1993. p 135-68.
9. 9. Valent P, Bettelheim P. The human basophil. Crit Rev Oncol Hematol 1990;10:327-52.
10. 10. Lantz CS, Boesiger J, Song C-H, Mach N, Kobayashi T, Mulligan RC, et al. Role for interleukin-3 in mast cell and hasophil development and in immunity to parasites. Nature 1998;392:90-3.
11. 11. Crimi E, Chiardamondia M, Milanese M, Rossi GA, Brusasco V. Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis 1991;144:1282-6.
12. 12. Church MK, Okayama Y, Bradding P. The role of the mast cell in acute and chronic allergic inflammation. Ann NY Acad Sci 1994;725:13-21.
13. 13. Miyachi Y, Kurosawa M. Mast cells in clinical dermatology. Australas J Dermatol 1998;39:14-8.
14. 14. Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328:257-65.
15. 15. Huang C, Sali A, Stevens RL. Regulation and function of mast cell proteases in inflammation. J Clin Immunol 1998;18:169-83.
16. 16. Galli SJ, Kitamura Y. Animal model of human disease: genetically mast cell-deficient W/Tv and Sl/Sld mice: their value for the analysis of the roles of mast cells in biological responses in vivo. Am J Pathol 1987;127:191-8.
17. 17. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997;90:1345-64.
18. 18. Nakano T, Sonoda T, Hayashi C, Yamatodani A, Kanayama Y, Yamamura T, et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intrapcritoneal and intravenous transfer into genetically mast cell-deficient W/Wv mice: evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985;162:1025-43.
19. 19. Nakano T, Kanakura Y, Nakahata T, Matsuda H, Kitamura Y. Genetically mast cell-deficient W/Wv mice as a tool of differentiation and function of mast cells. Fed Proc 1987;46:1920-3.
20. 20. Sylvestre DL, Ravetch JV. A dominant role for mast cell Fc receptors in the arthus reaction. Immunity 1996;5:387-90.
21. 21. Galli SJ, Wershil BK. The two faces of the mast cell (News and views). Nature 1996;381:21-2.
22. 22. Tsai M, Wedemeyer J, Ganiatsas S, Tam S-Y, Zon LI, Galli SJ. Phenotype and in vivo function of mast cells derived from mouse embryonic stem cells [abstract]. J Immunol. In press.
23. 23. Galli SJ, Lantz CS. Allergy. In Paul WE, editor. Fundamental immunology. 4th ed. Philadelphia: Lippincott-Raven; 1999. p 1137-84.
24. 24. Galli SJ. Mast cells and basophils. Curr Opin Hematol 2000;7:32-9.
25. 25. Galli SJ, Lichtenstein LM. Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, editors. Allergy: principles and practice. 3rd ed. St Louis: Mosby; 1988. p 106-34.
26. 26. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
27. 27. Holgate ST, Robinson C, Church MK. Mediators of immediate hypersensitivity. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis: Mosby; 1993. p 267-301.
28. 28. Galli SJ, Costa JJ. Mast cell-leukocyte cytokine cascades In allergic inflammation. Allergy 1995;50:851-62.
29. 29. Valone FH, Boggs JM, Goetzl EJ. Lipid mediators of hypersensitivity and inflammation. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis: Mosby; 1993. p 302-19.
30. 30. Young JD-E, Liu C-C, Butler G, Cohn ZA, Galli SJ. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci U S A 1987;84:9175-9.
31. 31. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990; 346:274-6.
32. 32. Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor-α (TNF-α)/cachectin by mouse mast cells stimulated by the FcεRI: a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 1991;174:103-7.
33. 33. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, et al. Mast cells can secrete VPF/VEGF and exhibit enhanced release after IgE-dependent upregulation of FcεRT expression. J Exp Med 1998;188:1135-45.
34. 34. Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwartz C, Kogel H, Welker P, et al. Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998;9:875-84.
35. 35. Yamatodani A, Maeyama K, Watanabe T, Wada H, Kitamura Y. Tissue distribution of histamine in a mutant mouse deficient in mast cells: clear evidence for the presence of non-mast-cell histamine. Biochem Pharmacol 1982;31:305-9.
36. 36. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999;400:769-72.
37. 37. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Eriksson I, et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999;400:773-6
38. 38. Zehnder JL, Galli SJ. Mast-cell heparin demystified [News and views]. Nature 1999;400:714-5.
39. 39. Schwartz LB. Tryptase, a mediator of human mast cells. J Allergy Clin Immunol 1990;86:594-8.
40. 40. Schwartz LB. Tryptase: a clinical indicator of mast cell-dependent events. Allergy Proc 1994;15:119-23.
41. 41. Li L, Li Y, Reddel SW, Cherrian M, Friend DS, Stevens RL, et al. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma allergy and drug-reactive patients. J Immunol 1998;161:5079-86.
42. 42. Caughey GH. Of mites and men: trypsin-like proteases in the lungs. Am J Respir Cell Mol Biol 1997;16:621-8.
43. 43. Pallaoro M, Fejzo MS, Shayesteh L, Blount JL, Caughey GH. Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. J Biol Chem 1999;274:3355-62.
44. 44. Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, Caughey GH. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A 1990;87:3811-5.
45. 45. Wastling JM, Knight P, Ure J, Wright S, Thornton EM, Scudamore CL, et al. Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the β-chymase, mouse mast cell protease-1. Am J Pathol 1998;153:491-504.
46. 46. Mencia-Huerta JM, Lewis RA, Razin E, Austen KF. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J Immunol 1983;131:2958-64.
47. 47. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor α which induces endothelial leukocyte adhesion molecule I. Proc Natl Acad Sci U S A 1991;88:4220-4.
48. 48. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, -6 and tumour necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10: 471-80.
49. 49. Okayama Y. Ono Y, Nakazawa T, Church MK, Mori M. Human skin mast cells produce TNF-α by substance P. Int Arch Allergy Immunol 1998;117(Suppl):48-51.
50. 50. Costa JJ, Church MK, Galli SJ. Mast cell cytokines in allergic inflammation. In: Holgate ST, Busse W, editors. Inflammatory mechanisms in asthma. New York: Marcel Dekker; 1997. p 111-27.
51. 51. Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995;181:1373-80.
52. 52. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, et al. Interleukin 3-dependent and -independent mast cells stimulaled with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245-57.
53. 53. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcεRI: role for mast cell-derived transforming growth factor b and tumor necrosis factor α. J Exp Med 1994;180:2027-37.
54. 54. Kendall JC, Li XH, Galli SJ, Gordon JR. Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor α and transforming growth factor β. J Allergy Clin Immunol 1997;99:113-23.
55. 55. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
56. 56. Jaffe JS, Raible DG, Post TJ, Wang Y, Glaum MC, Butterfield JH, et al. Human lung mast cell activation leads to IL-13 mRNA expression and protein release. Am J Respir Cell Mol Biol 1996;15:473-81.
57. 57. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997;99:1492-9.
58. 58. Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, Ra C, et al. IgE enchances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release. J Immunol 1999;162:5455-65.
59. 59. Okayama Y, Petit-Frère C, Kassel O, Semper A, Quint D, Tunon-de-Lara MJ, et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995;155:1796-808.
60. 60. Jaffe JS, Glaum MC, Raible DG, Post TJ, Dimitry E, Govindarao D, et al. Human lung mast cell IL-5 gene and protein expression: temporal analysis of upregulation following IgE-mediated activation. Am J Respir Cell Mol Biol 1995;13:665-75.
61. 61. Yano K, Yamaguchi M, de Mora F, Lantz CS, Butterfield JH, Costa JJ, et al. Production of macrophage inflammatory protein-Iα by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE binding ability. Lab Invest 1997;77:185-93.
62. 1. J Clin Invest 1992;90:35-41.
63. 63. Okayama Y, Kobayashi H, Ashman LK, Dobashi K, Nakazawa T, Holgate ST, et al. Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony stimulating factor in response to IgE-dependent stimulation. Eur J Immunol 1998;28:708-15.
64. 64. Kobayashi H, Okayama Y, Ishizuka T, Pawankar R, Ra C, Mori M. Production of IL-13 by human lung mast cells in response to Fcε receptor cross-linkage. Clin Exp Allergy 1998;28:1219-27.
65. 65. Ishizuka T, Okayama Y, Kobayashi H, Mori M. Interleukin-3 production by mast cells from human lung. Inflammation 1999;23:25-35.
66. 66. Ishizuka T, Okayama Y, Kobayashi H, Mori M. Interleukin-10 is localized to and released by human lung mast cells. Clin Exp Allergy 1999;10:1424-32.
67. 67. Bressler RB, Lesko J, Jones ML, Wasserman M, Dickason RR, Huston MM, et al. Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligation. J Allergy Clin Immunol 1997;99:508-54.
68. 68. Rumsaeng V, Cruikshank WW, Foster B, Prussin C, Kirshenbaum AS, Davis TA, et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 1997;159:2904-10.
69. 69. Zhang S, Anderson DF, Bradding P, Coward WR, Baddeley SM, MacLeod JD, et al. Human mast cells express stem cell factor. J Pathol 1998;186:59-66.
70. 70. Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996;26:13-9.
71. 71. Qu Z, Kayton RJ, Ahmadi P, Liebler JM, Powers MR, Planck SR, et al. Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules: morphological evidence for bFGF release through degranulation. J Histochem Cytochem 1998;46:1119-28.
72. 72. Oskeritzian C, Milon G, Braquet P, Mencia-Huerta JM, David B. Activated mast cells release biological activities able to support eosinophil production from mouse hemopoietic precursors. Cell Immunol 1996;167:205-15.
73. 73. Metzger H. The receptor with high affinity for IgE. Immunol Rev 1992;125:37-48.
74. 74. Turner H, Kinet J-P. Signalling through the high-affinity IgE receptor FcεRI. Nature 1999;402(Suppl):B24-30.
75. 75. Rottem M, Barbieri S, Kinet J-P, Metcalfe DD. Kinetics of the appearance of FcεRI-bearing cells in interleukin-3-dependent mouse bone marrow cultures: correlation with histamine content and mast cell maturation. Blood 1992;79:972-80.
76. - bone marrow progenitors express FcγRII hut do not express FcεRI until mast cell granule formation. J Immunol 1995;154:355-62.
77. neg mast cells in mouse bone marrow cultures: use of a monoclonal anti-p161 antibody. J Exp Med 1995;182:575-9.
78. 78. Rodewald H-R, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science 1996;271:818-22.
79. 79. Sterk AR, Ishizaka T. Binding properties of IgE receptors on normal mouse mast cells. J Immunol 1982;128:838-43.
80. 1-dependent passive anaphylaxis. J Clin Invest 1997;99:901-14.
81. 81. Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet J-P, et al. IgE regulates mouse basophil FcεRI expression in vivo. J Immunol 1997;158:2517-21.
82. 82. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, et al. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997;158:11438-45.
83. 83. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, et al. Down-regulation of FcεRI expression on human busophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-45.
84. 84. Shaikh N, Rivera J, Hewlett BR, Steak RH, Zhu F-G, Marshall JS. Mast cell FceRI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensis infection and can be up-regulated by in vivo administration of IgE. J Immunol 1997;158:3805-12.
85. 85. Ovary Z. Quantitative studies in passive cutaneous anaphylaxis of the guinea pig. Int Arch Allergy Appl Immunol 1952;3:162-74.
86. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987;139:2605-14.
87. 87. Wershil BK, Wang Z-S, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase responses in the mouse is mast cell dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J Clin luvest 1991;87:446-53.
88. 125I]fibrin deposition occurs at both early and late intervals of IgE-dependent or contact sensitivity reactions elicited in mouse skin: mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions. J Immunol 1990;145:3719-27.
89. 89. Martin TR, Takeishi T, Katz HR, Austen KF, Drazen JM, Galli SJ. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 1993;91:1176-82.
90. 90. Wershil BK, Furuta GT, Wang Z-S, Galli SJ. Mast cell-dependent neutrophil and mononuclearcell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996;110:1482-90.
91. 91. Takeishi T, Martin TR, Katona IM, Finkelman FD, Galli SJ. Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast-cell deficient and normal mice: mast cells arc not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. J Clin Invest 1991;88:598-608.
92. 92. Nagai H, Yamaguchi S, Tanaka H, The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. Ann N Y Acad Sci 1996;796:91-6.
93. 93. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, et al. Attenuation of allergic airway inflammation in 1L-4 deficient mice. Clin Exp Allergy 1994;24:73-80.
94. 94. Nogami M, Suko M, Okudatra H, Miyamonto T, Shiga J, Ito M, et al. Experimental pulmonary eosinophilia in mice by Ascaris suum extract. Am Rev Respir Dis 1990;414:1289-95.
95. 95. Mehlhop PD, van de Rijn M, Goldherg AB, Brewer JP, Kurup VP Martin TR, et al. Allergen-induced bronchial hyperreactivity and ensinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A 1997;94:1344-9.
96. 96. Corry DB, Grunig G. Hadeiha H, Kurup VR Warnock ML, Sheppard D, et al. Requirements tor allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998;4:344-55.
97. 97. Hamelmann E, Cieslewicz G, Schwarze J, Ishizuka T, Joetham A, Heusser C, et al. Anti-interleukin 5 hut not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am J Respir Crit Care Med 1999;160:934-41.
98. 98. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997;185:885-92.
99. 99. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997;186:449-54.
100. 100. MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice. Am J Respir Cell Mol Biol 1999;20:379-87.
101. 101. Galli SJ, Gordon JR, Wershil BK, Costa JJ, Elovic A, Wong DTW, et al. Mast cells and eosinophil cytokines in allergy and inflammation. In: Gleich GJ, Kay AB, editors, Eosinophils: immunological and clinical aspects. New York: Marcel Dekker; 1994. p 255-80.
102. 102. Kay AB, Barata L, Meng Q, Durham SR, Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 1997;113:196-9.
103. 103. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63.
104. 104. Hogan SP, Koskinen A, Foster PS. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 1997;75:284-8.
105. 105. Capron M, Desreumaux P. Immunobiology of eosinophils in allergy and inflammation. Res Immunol 1997;148:29-33.
106. 106. Hamelmann E, Oshiba A, Paluh J, Bradley K, Loader J, Potter TA, et al. Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J Exp Med 1996;183:1719-29.
107. 107. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399-408.
108. 108. Kay AB. T cells as orchestrators of the asthmatic response. Ciba Found Symp 1997;206:56-70.
109. 109. Zuany-Amorim C, Ruffle C, Haile S, Vargaftig BB, Pereira P, Pretolani M. Requirement for γδ T cells in allergic airway inflammation. Science 1998;280:1265-7.
110. 110. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 1998;157:210-8.
111. 111. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994;105:687-96.
112. 112. Frew AJ. Cytokines, chemokines, T cells and allergy [editorial]. Clin Exp Allergy 1996;26:2-4.
113. 113. Kapsenberg ML, Hilkens CM, Jansen HM, Bos JD, Snijders A, Wierenga EA. Production and modulation of T-cell cytokines in atopic allergy. Int Arch Allergy Immunol 1996;110:107-13.
114. 114. Daser A, Meissner N, Herz U, Renz H. Role and modulation of T-cell cytokines in allergy. Curr Opin Immunol 1995;7:762-70.
115. 115. Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DT, Gordon JR, et al. Human eosinophils can express the cytokines tumor necrosis factor-α and macrophage inflammatory protein-1 α. J Clin Invest 1993;91:2673-84.
116. 116. Lemanske RF Jr, Kaliner MA. Late phase allergic reactions. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, editors. Allergy: principles and practice. 3rd edition. St Louis: Mosby; 1988. p 224-46.
117. 117. Takizawa H, Ohtoshi T, Kikutani T, Okazaki H, Akiyama N, Sato M, et al. Histamine activities bronchial epithelial cells to release inflammatory cytokines in vitro. Int Arch Allergy Immunol 1995;108:260-7.
118. 118. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier IA, Ueki IF, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A 1999;19:3081-6.
119. 119. de Mora F, Williams CMM, Frenette PS. Wagner DD, Hynes RO, Galli SJ. P-and E-selectins are required for the leukocyte recruitment, but not the tissue swelling, associated with IgE, and mast cell-dependent inflammation in mouse skin. Lab Invest 1998;78:497-505.
120. 120. Wershil BK, Furuta GT, Lavigne JA, Roy Choudhury A, Wang Z-S, Galli SJ. Dexamethasone or cyclosporin A suppresses mast cell-leukocyte cytokine cascades: multiple mechanisms of inhibition of IgE-and mast cell-dependent cutaneous inflammation in the mouse. J Immunol 1995;154:1391-8.
121. 121. Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999;402(Suppl):B31-8.
122. 122. Busse WW. Inflammation in asthma: the cornerstone of the disease and target of therapy. J Allergy Clin Immunol 1998;102(Suppl):S17-22.
123. 123. Kips JC, Tavernier J, Pauwels A. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992;145:332-6.
124. 124. Finotto S, Ohno I, Marshall JS, Gauldie J, Denburg JA, Dolovich J, et al. TNF-α production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994;153:2278-89.
125. 125. Ohkawara Y, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H, et al. Human lung mast cells and pulmonary macrophages produce tumour necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992;7:385-92.
126. 126. MacIntyre D, Boyd G. Factors influencing the occurrence of a late reaction to allergen challenge in atopic asthmatics. Clin Allergy 1984;14:311-7.
127. 127. Sulakelidze I, Inman MD, Rerecich T, O'Bryne PM. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998;11:821-7.
128. 128. Galli SJ. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J Exp Med 1997;186:343-7.
129. 129. Kung TT, Stelts D, Zurcher JA, Jones H, Umland SP, Kreutner W, et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 1995;12:404-9.
130. 130. Williams CMM, Wang ZS, Galli SJ. Mast cells are required for the airway hyperresponsiveness, lung eosinophilia and epithelial proliferation associated with a mouse model of chronic asthma [abstract]. Int Arch Allergy Immunol. In press.
131. 131. Das AM, Flower RJ, Perretti M. Resident mast cells are important for eotaxin-induced eosinophil accumulation in vivo. J Leukoc Biol 1998;64:156-62.
132. 132. Harris RR, Komater VA, Marett RA, Wilcox DM, Bell RL. Effect of mast cell deficiency and leukotriene inhibition on the influx of eosinophils induced by eotaxin. J Leukoc Biol 1997;62:688-91.
133. 133. Hogaboam C, Kunkel SL, Strieter RM, Taub DD, Lincoln P, Standiford TJ, et al. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 1998;160:6166-71.
134. 134. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-9.
135. 135. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;20:171-9.
136. 136. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39:131-6.
137. 137. Wilson JW. What causes airway remodeling in asthma? Clin Exp Allergy 1998;28:534-6.
138. 138. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997;156:229-33.
139. 139. Roche WR. Fibroblasts and asthma. Clin Exp Allergy 1991;21:545-8.
140. 140. Brewster LEP, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-11.
141. 141. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 1999;29:2645-9.
142. 142. Shapiro SD, Senior RM. Matrix metalloproteinases: matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-2.
143. 143. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A 1994;26:3739-43.
144. 1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific β-chymase, mouse mast cell protease-1. Blood 1999;93:3473-86.
145. 145. Fang KC, Wolters PJ, Steinhoff M, Bidgel A, Blount JL, Caughey GH. Mast cell expression of gelatinase A and B is regulated by kit ligand and TGF-β. J Immunol 1999;162:5528-35.
146. 146. de Paulis A, Minopoli G, Dal Piaz F, Pucci P, Russo T, Marone G. Novel autocrine and paracrine loops of the stem cell factor/chymase network. Int Arch Allergy Immunol 1999;118:422-5.
147. 147. Welker P, Grabbe J, Gibbs B, Zuberbier T, Henz BM. Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor. Scand J Immunol 1999;49:495-500.
148. 148. Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, et al. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci U S A 1997;94:9017-21.
149. 149. Pare PD, Bai TR. The consequences of chronic allergic inflammation. Thorax 1995;50:328-32.
150. 150. Goldstein RA, Paul WE, Metcalfe DD, Busse WW, Reece ER. NIH conference: asthma. Ann Intern Med 1994;121:698-708.
151. 151. Drazen JM, Arm JP, Austen KF. Sorting out the cytokines of asthma. J Exp Med 1996;183:1-5.
152. 152. Lin S, Cicala C, Scharenberg AM, Kinet J-P. The FcεRIβ subunit functions as an amplifier of FcεRIγ-mediated cell activation signals. Cell 1996;85:985-95.
153. 153. Dombrowicz D, Lin S, Flamand V, Brini AT, Koller BH, Kinet JP. Allergy-associated FcRβ is a molecular amplifier of IgE-and IgG-mediated in vivo responses. Immunity 1998;8:517-29.
154. 154. Hsu C, MacGlashan D Jr. IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol Lett 1996;52:129-34.
155. 155. Banovac K, Neylan D, Leone J, Ghandur-Mnaymneh L, Rabinovitch A. Are the mast cells antigen presenting cells? Immunol Invest 1989;18:901-6.
156. 156. Tkaczyk C, Villa I, Peronet R, David B, Mecheri S. FcεRI-mediated antigen endocytosis turns IFN-γ-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology 1999;97:333-40.
157. 157. Frandji P, Tkaczyk C, Oskeritzian C, Lapeyre J, Peronet R, David B, et al. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-γ. Cell Immunol 1995;163:37-46.
158. 158. Yang PC, Berin MC, Perdue MH. Enhanced antigen transport across rat tracheal epithelium induced by sensitization and mast cell activation. J Immunol 1999;163:2769-76.
159. 159. Berin MC, Kiliaan AJ, Yang PC, Groot JA, Kitamura Y, Perdue MH. The influence of mast cells on pathways of transepithelial antigen transport in rat intestine. J Immunol 1998;161:2561-6.
160. 160. Maurer D, Fiebiger S, Ebner C, Reininger B, Fischer GF, Wichlas S, et al. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα-and FcεRIγ-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157:607-16.
161. 161. Maurer D, Ebner C, Reininger B, Petzelbauer P, Fiebiger E, Stingl G. Mechanisms of FcεRI-IgE-facilitated allergen presentation by dendritic cells. Adv Exp Med Biol 1997;417:175-8.
162. 162. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blassey H, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993;365:340-3.
163. 163. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C. Central role of immunoglobulin (Ig) E in the induction of lung ensinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactngenic and anti-IgE antibody. J Exp Med 1996;183:1303-10.
164. 164. Wong DTW, Elovic A, Matossian K, Nagura N, McBride J, Chou MY, et al. Eosinophils from patients with blood eosinophilia express transforming growth factor-β1. Blood 1991;78:2702-7.
165. 165. Ohno I, Lea RG, Flanders KC, Clark DA, Banwalt D, Dolovich J, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor-β1 gene (TGFβ1). J Clin Invest 1992;89:1662-68.
166. 166. Wong DTW, Weller PF, Galli SJ, Elovic A, Rand TH, Gallagher GT, et al. Human eosinophils express transforming growth factor-alpha. J Exp Med 1990;172:673-81.